| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
CurcuminReceptor (PPAR gamma)Inflammatory bowel diseasesEpigeneticsPancreas (Neoplasia)| 1 | 2004 | Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by Curcumin. | 
| + | - | nl | Arch Pharm Res 27(7):683-92 (2004) |
| 2 | 2007 | Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-gamma Activation. |
| + | - | nl | PPAR Res 2007(-):89369 (2007) |
| 3 | 2009 | Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? |
| + | - | nl | AAPS J 11(3):495-510 (2009) |
| 4 | 2007 | Neuroprotective effects of curcumin. |
| + | - | nl | Adv Exp Med Biol 595(-):197-212 (2007) |
| 5 | 2011 | Curcumin for inflammatory bowel disease: a review of human studies. |
| + | - | nl | Altern Med Rev 16(2):152-6 (2011) |
| 6 | 2009 | Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. |
| + | - | nl | Altern Med Rev 14(2):141-53 (2009) |
| 7 | 2009 | Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. |
| + | - | nl | Int J Biochem Cell Biol 41(1):40-59 (2009) |
| 8 | 2010 | Development of curcumin as an epigenetic agent. |
| + | - | nl | Cancer 116(20):4670-6 (2010) |
